Skip to main content
. 2021 Nov 27;13(11):1777–1790. doi: 10.4254/wjh.v13.i11.1777

Table 2.

Comparison of comorbid conditions and complications for patients hospitalized with Clostridioides difficile infection with coexisting nonalcoholic fatty liver disease, viral liver disease and alcoholic liver disease

Variables
CDI with NAFLD
CDI with VLD
CDI with ALD
P value
n (weighted)
7239
11857
5938
CDI with NAFLD vs CDI with VLD
CDI with NAFLD vs CDI with ALD
Number of Elixhauser comorbidities < 0.0001 < 0.0001
0 0 (0%) 114 (1%) -
1 244 (3.4%) 574 (4.8%) 116 (2%)
2 656 (9.1%) 1409 (11.9%) 354 (6%)
≥ 3 6338 (87.6%) 9760 (82.3%) 5463 (92%)
Obesity 2012 (27.8%) 850 (7.2%) 372 (6.3%) < 0.0001 < 0.0001
Diabetes 2750 (38%) 3451 (29.1%) 1170 (19.7%) < 0.0001 < 0.0001
Hypertension 4300 (59.4%) 6347 (53.5%) 2980 (50.2%) 0.00058 < 0.0001
Dyslipidemia 2619 (36.2%) 1868 (15.8%) 905 (15.2%) < 0.0001 < 0.0001
Hepatocellular carcinoma - 253 (2.1%) 45 (0.8%) < 0.0001 0.0217
Cirrhosis related comorbidities1
Cirrhosis 401 (5.5%) 2508 (21.2%) 3407 (57.4%) < 0.0001 < 0.0001
Number of cirrhosis complications 0.0013 < 0.0001
0 137 (34.2%) 1773 (70.7%) 2105 (61.8%)
1 244 (60.8%) 688 (27.4%) 1104 (32.4%)
v ≥ 2 20 (5.0%) 47 (1.9%) 198 (5.8%)
Ascites 0 (0%) 0 (0%) 0 (0%) NA NA
Esophageal varices bleeding 0 (0%) - 20 (0.6%) NA NA
Hepatic encephalopathy 110 (27.4%) 60 (2.4%) 569 (16.7%) 0.003338 < 0.0001
Hepatorenal syndrome 0 (0%) 15 (0.6%) 33 (1.0%) NA NA
Portal hypertension 175 (43.6%) 661 (26.4%) 843 (24.7%) < 0.0001 < 0.0001
Spontaneous bacterial peritonitis 0 (0%) 38 (1.5%) 40 (1.2%) NA NA
1

Value reported as percentage of all cirrhotic patients.

Values reported as weighted number [n (%)].-: Numbers were not displayed due to extremely small numbers were associated with increased risk for identification of persons; CDI: Clostridioides difficile infection; NAFLD: Nonalcoholic fatty liver disease; VLD: Viral liver disease; ALD: Alcoholic liver disease; NA: Not available.